Risk Assessments for Type 1 Wild Poliovirus and Type 2 Vaccine-Derived Poliovirus Importation and Transmission

[1]	Lee SE, Greene SA, Burns CC, Tallis G, Wassilak SGF, Bolu O, et al. Progress toward poliomyelitis eradication - Worldwide, January 2021-March 2023. MMWR Morb Mortal Wkly Rep 2023;72(19):517 − 22. https://doi.org/10.15585/mmwr.mm7219a3.
[2]	Global Polio Eradication Initiative. Wild poliovirus list.https://polioeradication.org/wild-poliovirus-count/.pdf. [2023-12-19].
[3]	World Health Organization. Statement of the thirty-fifth polio IHR emergency committee. 2023. https://www.who.int/news/item/12-05-2023-statement-of-the-thirty-fifth-polio-ihr-emergency-committee. [2023-5-12].
[4]	Global Polio Eradication Initiative. Global circulating vaccine-derived poliovirus (cVDPV). https://polioeradication.org/circulating-vaccine-derived-poliovirus-count [2024-1-9].
[5]	Link-Gelles R, Lutterloh E, Ruppert PS, Backenson PB, St. George K, Rosenberg ES, et al. Public health response to a case of paralytic poliomyelitis in an unvaccinated person and detection of poliovirus in wastewater-New York, June-August 2022. Am J Transplant 2022;22(10):2470-4. http://dx.doi.org/10.1111/ajt.16677.
[6]	Zuckerman NS, Bucris E, Morad-Eliyahu H, Weiss L, Vasserman R, et al. Environmental surveillance of a circulating vaccine-derived poliovirus type 2 outbreak in Israel between 2022 and 2023: a genomic epidemiology study. Lancet Microbe. [2024-9-13]. https://doi.org/10.1016/S2666-5247(24)00116-2
[7]	World Health Organization. Detection of circulating vaccine derived polio virus 2 (cVDPV2) in environmental samples– the United Kingdom of Great Britain and Northern Ireland and the United States of America. 2022. https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON408. [2022-9-14].
[8]	Zhang Y, Luo HM, Wen N, Cui FQ, Wang HB. A study of risk assessment tool on wild poliovirus importation and transmission. Chin J Vaccin Immun 2013;19(1):17-9,80. http://qikan.cqvip.com/Qikan/Article/Detail?id=45099556. (In Chinese).
[9]	Kang W, Wen N, Wen Y, Yang YZ, Zhang P, Yang H. Construction of a risk assessment tool for importation and transmission of type 2 poliovirus in China using a modified Delphi method. Chin J Vaccin Immun 2023;29(4):377 − 82. https://doi.org/10.19914/j.CJVI.2023064.
[10]	Lowther SA, Roesel S, O'Connor P, Landaverde M, Oblapenko G, Deshevoi S, et al. World Health Organization regional assessments of the risks of poliovirus outbreaks. Risk Anal 2013;33(4):664 − 79. https://doi.org/10.1111/risa.12032.
[11]	Kalkowska DA, Duintjer Tebbens RJ, Thompson KM. Environmental surveillance system characteristics and impacts on confidence about no undetected serotype 1 wild poliovirus circulation. Risk Anal 2019;39(2):414 − 25. https://doi.org/10.1111/risa.13193.
[12]	Duintjer Tebbens RJ, Pallansch MA, Cochi SL, Ehrhardt DT, Farag NH, Hadler SC, et al. Modeling poliovirus transmission in pakistan and afghanistan to inform vaccination strategies in undervaccinated subpopulations. Risk Anal 2018;38(8):1701 − 17. https://doi.org/10.1111/risa.12962.
[13]	Camphor HS, Bareja C, Glynn-Robinson A, Polkinghorne BG, Durrheim DN. A novel semi-quantitative methodology for national poliovirus reintroduction and outbreak risk assessment. Travel Med Infect Dis 2021;44:102181. https://doi.org/10.1016/j.tmaid.2021.102181.
[14]	Ye JK, Cao L, Yu WZ, Song YF, Yin ZD. Reported routine immunization coverage with National Immunization Program vaccines in China, 2020-2021. Chin J Vaccin Immun 2022;28(5):576 − 80. https://doi.org/10.19914/j.CJVI.2022110.
[15]	Yang H, Fan CX, Zhu SL, Wang FZ, Li YQ, Tang L, et al. Surveillance for acute flaccid paralysis among children less than 15 years of age in China, 2017-2019. Chin J Vaccin Immun 2021;27(2):152 − 6,172. https://doi.org/10.19914/j.CJVI.2021018.
[16]	Yang H, Fan CX, Cao L, Ma C, Hao LX, Yin ZD, et al. Risk assessment for wild poliovirus importation and transmission at subnational levels of China in 2019. Chin J Vaccin Immun 2020;26(3):261 − 4,286. https://d.wanfangdata.com.cn/periodical/zgjhmy202003005. (In Chinese).
[17]	Chinese Preventive Medicine Association. Expert consensus on informed consent for vaccination (Part One). Pract Prev Med 2021;28(4):385 − 411. https://doi.org/10.3969/j.issn.1006-3110.2021.04.001.
[18]	World Health Organization. Polio vaccines: WHO position paper – June 2022. Wkly Epidemiol Record 2022;97(25):277 − 300. https://www.who.int/publications/i/item/WHO-WER9725-277-300#:~:text=Polio%20vaccines:%20WHO%20position%20paper%20%E2%80%93%20June%202022.%20Weekly%20Epidemiological.